2021
DOI: 10.1016/j.ejrad.2021.109893
|View full text |Cite
|
Sign up to set email alerts
|

Prostate cancer: Molecular imaging and MRI

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 177 publications
0
5
0
Order By: Relevance
“…The true clinical significance of missed tumor foci that cannot be detected on MRI remains controversial [27]. Recently, ligands for prostate-specific membrane antigens have been introduced into positron emission tomography for the diagnosis and management of PCa and have been useful in identifying the location of PCa and assessing tumor volume, which cannot be determined by MRI [28,29]. Future advances in diagnostic imaging may allow the precise identification of PCa location and tumor volume.…”
Section: Discussionmentioning
confidence: 99%
“…The true clinical significance of missed tumor foci that cannot be detected on MRI remains controversial [27]. Recently, ligands for prostate-specific membrane antigens have been introduced into positron emission tomography for the diagnosis and management of PCa and have been useful in identifying the location of PCa and assessing tumor volume, which cannot be determined by MRI [28,29]. Future advances in diagnostic imaging may allow the precise identification of PCa location and tumor volume.…”
Section: Discussionmentioning
confidence: 99%
“…Several ligands are employed in clinical practice and others are being investigated, especially for the detection of early relapse after local therapy in a biochemical recurrence (BCR) setting, when PSA levels are rising. This is due to higher detection rate of local and distant relapse by PET imaging compared to standard imaging, such as a computed tomography (CT) scan and total bone scintigraphy [ 42 , 43 ]. The 18-fluorodeoxyglucose (FDG)-PET, differently to other types of cancer, has a limited role in PCa.…”
Section: Radiometabolic Approaches In Mcrpcmentioning
confidence: 99%
“…MR imaging can provide high-resolution quality images for the soft tissues and cells without damaging the cell functions. It would be great significance to integrate MRI with optical imaging for more robust acquisition of biological events with higher spatial resolution [18][19][20]. Superparamagnetic iron oxide nanoparticles (SPION) with multifunctional properties have been widely investigated as carriers of anticancer drugs for drug delivery systems and as contrast agents for magnetic resonance imaging [21][22][23].…”
Section: Introductionmentioning
confidence: 99%